Main | Registration | Speakers | Schedule | Sponsorship | FAQ

2021 AAOM Virtual Annual Conference Speakers

Get to Know the Experts!

Register for AAOM 2021

Speakers are listed in alphabetical order by last name.

Maha Al-MohoyaMaha Al-Mohaya, BDS, MSc, DMSc, ABOM diplomate

Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts | Saudi Arabia

Dr. Al-Mohaya has obtained her American Board of Oral Medicine in 2005 (As the First Saudi Doctor). In 2006 she completed her Doctorate of Medical Science in Oral Biology from Harvard University/USA. In 2015, she established Oral Medicine and Special Care Dentistry in the dental center at Prince Sultan Military Medical City (PSMMC). She got her fellowship of Laser Therapy in Dentistry from Aachen University/Germany in 2016. Dr. Al-Mohaya is the founder of the Saudi Board of Oral Medicine & Pathology Program in 2017. She published several papers, worked as a chief editor deputy of Saudi Medical Journal and served in several leadership positions, including Medical Admin for Physicians Affairs at PSMMC Currently, Dr. Al-Mohaya works as Chairman & Consultant of Oral Medicine and Special Care Dentistry & Chairman of Dental Research Group at PSMMC, and Chairman of the Scientific Council of Oral Medicine & Pathology at Saudi Commission for Health Specialties.

Marcelo W.B. Araujo, DDS, MS, PhDMarcelo W.B. Araujo, DDS, MS, PhD

OM-COVID Session | Can Dentists Play a Role in Ending the Pandemic?

Dr. Marcelo Araujo is the Chief Executive Officer of the ADA Science & Research Institute (ADASRI) and the American Dental Association (ADA) Chief Science Officer. Dr. Araujo is an experienced researcher with broad knowledge in clinical research, regulatory affairs and R&D strategy. With over 25 years of healthcare experience he is committed to improving oral health globally through research and public health policy.

Prior to Industry, Dr. Araujo held academic positions both in the United States and in Brazil, where he also practiced dentistry in his hometown of Rio de Janeiro. Dr. Araujo holds a DDS degree (1994) and Periodontology Certificate (1997) from the University Gama Filho, from Rio de Janeiro, Brazil, a MS in Oral Science (1999) and a PhD in Epidemiology (2003) from the University at Buffalo, where he also completed a Fellowship in Periodontology Teaching and Clinical Research, in 2003. Most recently, in 2019, Dr. Araujo completed the Kellogg Executive Scholar Certificate in Nonprofit Management, at the Northwestern University, Kellogg School of Management.

Siri Bier-JensenSiri Bier-Jensen, DDS, PhD

World Workshop on Oral Medicine

Head of Department of Dentistry and Oral Health, Faculty of Health at Aarhus University, Denmark. Graduated as DDS from University of Copenhagen in 1998 and PhD in 2006 (oral complications induced by cancer chemotherapy). Research focus on salivary gland dysfunction, and oral complications of cancer therapies. Experience of teaching oral medicine, oral physiology and anatomy on a pre- and postgraduate level and practicing oral medicine in a university referral clinic. Steering Committee Member of the World Workshop on Oral Medicine. Board Member of the International Society of Oral Oncology (ISOO). Co-Section Head of the Salivary Gland Hypofunction and Xerostomia Clinical Management Guideline Group, joint guideline development by ISOO, Multinational Association of Supportive Care in Cancer (MASCC) and American Society of Clinical Oncology (ASCO). Professional skills: Oral medicine, oral oncology, dentistry, research and education, leadership in a university setting, board expertise.

Qianming ChenQianming Chen, DDS, PhD

Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts | China

Qianming Chen, DDS, PhD, is current Chair Professor, Qiuse, Distinguished Professor, Dean for Dental School & Stomatology Hospital Zhejiang University. He is one of the outstanding committee members of Chinese Stomatological Association (CSA). He was the 5th President of Society of Oral Medicine, CSA and is the 7th Vice President of this Society, too. He is also the Secratry-General for the Chinese Section of International College of Dentists (ICD). He has edited the General Textbook of Oral Medicine for Dental students all over China , and He was the interpreter-in-chief for Burkit's Oral Medicine (Chinese Version). He is an active outstanding pioneer for Oral Medicine in China at the teaching, researching, practicing, and managing.

Mark DrangsholtMark Drangsholt, DABOM, FDS RCSEd

Clinicopathologic Expert Panel

For the past 26 years, he has provided patient care in the Oral Medicine Clinical Service, and for the past 10 years at The Center for Pain Relief, the first multidisciplinary pain clinic in the world, both at the University of Washington. His clinical practice focuses on the diagnosis and non-surgical management of orofacial pain, oral mucosal lesions, and other oral-facial disorders. He is the current past-president of the American Board of Oral Medicine, author of over 80 peer-reviewed scientific articles, 10 book chapters, over 130 published abstracts and has given over 150 presentations worldwide. His NIH-funded research has focused on measuring neurosensory abnormalities in the craniofacial region. His current research projects include devising new methods to rapidly diagnose orofacial pain conditions, measuring the global prevalence and disability from orofacial pain conditions, and developing personalized science -“N of 1” research methodologies to evaluate health, wellness, and clinical outcomes.

Justin DurhamJustin Durham, BDS MFDSRCS FDSRCS (OS)

Plenary Session 1C | Disease Definition and Diagnostic Criteria in Neuropathic Pain: A Call for Consensus

Justin is a Professor of Orofacial Pain and Head of the School of Dental Sciences at Newcastle University and an Honorary Consultant Oral Surgeon at Newcastle-Upon-Tyne’s Hospitals’ NHS Foundation Trust in the UK. He was appointed Clinical Fellow/Hon SpR in Oral Surgery at Newcastle University in 2003. He obtained his PhD, “Ideologies and outcomes in Temporomandibular Disorders (TMD)”, from Newcastle University in 2008. He subsequently completed his Oral Surgery specialist training and also became the first person in the UK to pass the American Board of Orofacial Pain. He held a prestigious NIHR Clinician Scientist award from 2012-2017, which funded his research into the care pathways in chronic orofacial pain and was promoted to a personal chair in 2017. In his clinical practice he has established and leads a multidisciplinary orofacial pain clinic that receives tertiary-level referrals from both dental and medical specialties in the North of England.

Arwa FaragArwa Farag, BDS, DMSc, Dip ABOM, Dip ABOP, FRCSEd

World Workshop on Oral Medicine

Dr. Arwa Farag is an Assistant Professor and a Consultant of Oral Medicine, Orofacial Pain, and Dental Sleep Medicine at the Department of Oral Diagnostic Sciences, Faculty of Dentistry, King AbdulAziz University, Jeddah Saudi Arabia (FDKAU). She is also an assistant professor at the Department of Diagnostic Sciences, Tufts University School of Dental Medicine (TSDM), Boston, MA, USADr. Farag graduated from King Saud University, Riyadh, Saudi Arabia. She completed her residency training in oral medicine at the Brigham and Women's Hospital and earned her Doctor of Medical Science Degree (DMSc) from Harvard School of Dental Medicine. She also completed her fellowship in TMD/orofacial pain at TUSDM. Dr. Farag is a Diplomat of the American Board of Oral Medicine, a Diplomat of the American Board of Orofacial Pain, and a Fellow of The Royal College of Surgeon of Edinburgh. Dr. Farag is an active member and participants of the American Academy of Oral Medicine, the European Association of Oral Medicine, the American Academy of Orofacial Pain, the American Association of Dental Research, and the International Association of Dental Research. She is currently serving as a chair for the Scientific Sessions Committee of the American Academy of Oral Medicine and a steering member of the World Workshop on Oral Medicine.

Jennifer GrandisJennifer Grandis, MD

Plenary Session 2B | Beyond the Phenotypic Characteristics of Dysplasia: Insights into the Future

Dr. Jennifer R. Grandis is a physician scientist whose research is focused on elucidating and targeting key signaling pathways and genomic alterations in head and neck cancer with the goals of enabling precision medicine studies based on strong studies in relevant models. She has leveraged her access to head and neck cancer (HNC) patients and their biospecimens to optimize translational research studies that include developing novel therapies in the laboratory for clinical application as well as generating and interrogating relevant preclinical models to determine the underlying mechanism of clinical findings. In her institutional roles at the University of Pittsburgh and since 2015, at UCSF, she has facilitated collaborations between clinicians and investigators with an emphasis of developing a robust research infrastructure to support clinical and translational cancer studies. She has published over 350 papers in the peer-reviewed literature and she has been continuously funded by the NIH since joining the faculty in 1993. Dr. Grandis is an elected member of the American Society for Clinical Investigation the Association of American Physicians and the National Academy of Medicine. She is an American Cancer Society Clinical Research Professor.

Amanda HollingerAmanda Hollinger, MPA

Plenary Session 1A | Oral Cancer Awareness: Support, Advocacy, and Hope for Better Outcomes

Amanda Hollinger has served as Executive Director of the Head and Neck Cancer Alliance since 2018. With more than 20 years of experience in the nonprofit and public sector, Amanda has held leadership positions in a variety of organizations, including the YWCA of Greater Charleston, Trident Technical College, and as a nonprofit consultant. Her skills include fundraising, federal and foundation grant writing, advocacy, community outreach, and organizational development. Co-authored publications related to head and neck cancer include: Yan, et. al. (2020). The role of head and neck cancer advocacy organizations during the COVID‐19 pandemic. Head & Neck: Journal of the Sciences and Specialties of the Head & Neck (Vol 42, Issue 7) and Reed, et. al. (2010. Oral Cancer Preventive Practices of South Carolina Dentists and Physicians. Journal of Cancer Education (Volume 25), pages 166–173. Amanda received her Bachelor’s degree from Guilford College in Greensboro, North Carolina, and her Master’s degree in Public Policy from the Humphrey School of Public Affairs at the University of Minnesota.

Ross KerrRoss Kerr, DDS, MSD

World Workshop on Oral Medicine

Dr. Ross Kerr received his DDS from McGill University in Montreal, Canada, and his MSD and certificate in Oral Medicine at the University of Washington. He is a Diplomate of the American Board of Oral Medicine and Clinical Professor in the Department of Oral & Maxillofacial Pathology, Radiology & Medicine at New York University College of Dentistry. He is a past president of the American Academy of Oral Medicine, a steering committee member of the World Workshop on Oral Medicine, a director of the American Board of Oral Medicine, and he serves as a member of the Scientific Advisory Board for the Oral Cancer Foundation.

Peter Lockhart, DDSPeter Lockhart, DDS

Oral Medicine Practice Session Lecture 1 | Infective Endocarditis Prevention: An Oral Medicine Researcher’s Perspective

Peter Lockhart, DDS, graduated from University of North Carolina School of Dentistry. After a two-year General Practice Residency at Medical Center Hospital of Vermont, he joined the faculty at Brigham and Women's Hospital in Boston where he directed the GPR program, practiced general dentistry and oral medicine, and conducted clinical research. He was Chair, Department of Oral Medicine at Carolinas Medical Center for 26 years, where he is now Research Professor focusing on multiple funded clinical studies. He has a variety of research interests concerning the dental management of medically complex patients. He has had funding for bacteremia and endocarditis research for over 25 years, and since 2004, he has been the American Dental Association liaison to the American Heart Association's Committee on Endocarditis. He has over 175 books, textbook chapters, and peer reviewed journal articles, and is the editor of the textbook, Oral Medicine and Medically Complex Patients.

Giovanni LodiGiovanni Lodi, PhD

World Workshop on Oral Medicine

Giovanni Lodi qualified in Dentistry at the Università degli Studi di Milano in 1991. In 1998 he obtained his PhD from the University of London, and the same year he started to work for the oral medicine service of the dental clinic of the university hospital of Milano (Italy). In 2002 he joined the Faculty of Medicine and Dentistry of the Università degli Studi di Milano. He has published more than 200 papers in the field of oral medicine, evidence based dentistry and special needs. Current positions: associate professor with clinical duties of the Università degli Studi di Milano (2015-); honorary senior lecturer of the Department of Oral Medicine - Eastman Dental Institute-UCL London (2004-); member of the Steering Committee of the World Workshop on Oral Medicine (2011-); editor in chief of Dental Cadmos, the most widely read Italian dental journal (2011-); editor of the Cochrane Oral Health Review Group (2013-); and editor in chief of Oral Diseases, the International leading journal in oral medicine (IF 2.61) (2017-).

Cesar MiglioratiCesar Migliorati, DDS, MS, PhD

Samuel Charles Miller Lecture: Pathway to Discovery

Dr. Migliorati is Associate Dean of Clinical Affairs and Quality Assurance at the University of Florida College of Dentistry and a professor in oral medicine. He graduated from Sao Paulo University (USP), Brazil. He holds two MSs in Stomatology (USP) and Oral Biology (UCSF). He received his PhD from USP in the field of Stomatology, and is board certified by the American Board of Oral Medicine. He is a member of the American Academy of Oral Medicine since 1988, a member of the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO), and the current President of the American Board of Oral Medicine. He is a member of the mucositis study group of MASCC/ISOO and was one of the leaders who led the work of the use of Photobiomodulation (PBM) in the mucositis guidelines. He collaborates with oncology groups around the world and focus in the areas of supportive care in cancer and oral complications of cancer therapy. He has over 100 peer-reviewed publications.

Foluso OwotadeFoluso Owotade, BChD, PhD, FWACS

Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts | Nigeria

Professor and past Dean, Faculty of Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria. Consultant at the University Teaching Hospital, Ile-Ife, Nigeria (since March 1998) Previously, Director of Clinical Services and Training and Acting Chief Medical Director. His training covers the fields of Oral/Maxillofacial Surgery, Oral Medicine, Oral Microbiology and Biostatistics/Clinical Research. He was educated at the Obafemi Awolowo University, Ile-Ife, Nigeria (1983-1989; 1992-1997), University of California, San Francisco, USA (2005-2006), University of the Witwatersrand, Johannesburg, South Africa (2011-2014). Professor Owotade initiated the Oral Medicine clinical services and residency at Ile-Ife, in 2006 and passionate to develop Oral Medicine and Oral Biology in Nigeria to enhance training, research and patient management. He has trained 24 specialists in Oral/Maxillofacial Surgery and Oral Medicine, also supervised 4 Masters and 2 PhD candidates. He’s published 75 scientific articles and three book chapters. His hobbies include reading and cycling. He is married and blessed with children.

Joel PalefskyJoel Palefsky, MD, CM, FRCP(C)

Sol Silverman Lecture | Location, Location, Location: influence of local factors in the outcome of mucosal HPV infection

Plenary Session 2C | Oral Neoplasia in People Living with HIV: Divide, Detect and Conquer

Joel Palefsky, MD, CM, FRCP(C) is Professor of Medicine and Infectious Diseases at the University of California San Francisco School of Medicine. He is an internationally recognized expert on the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the vice-chair of the National Cancer Institute (NCI)-supported AIDS Malignancy Consortium. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer and to identify biomarkers of progression. He is founder and past president of the International Anal Neoplasia Society and is past president of the International Papillomavirus Society.

David PorterDavid Porter, MD

Plenary Session 2A | Chimeric Antigen Receptor (CAR) T-cell Therapy: The Current Success and the Future Promises in Combating Hematologic Neoplasia

Dr. Porter is the Jodi Fisher-Horowitz Professor and Director of Cell Therapy and Transplant at the University of Pennsylvania and Abramson Cancer Center. He graduated the University of Rochester, earned a medical degree at Brown University, completed residency at Boston University Hospital, and fellowship at Brigham and Women’s Hospital and Harvard Medical School. Dr. Porter is an accomplished clinical investigator with interests in development of novel approaches to cellular therapy and stem cell transplantation. He is the Deputy Editor of the Journal of Transplantation and Cell Therapy, and Associate Editor for the American Journal of Hematology. He chairs or serves on numerous local, national and international committees focused on stem cell transplantation and cell therapy. He is the immediate past Chair and member of the Board of Directors of the National Marrow Donor Program and is the recipient of several prestigious awards that include recognition for Professionalism and Mentorship.

Cameron RandallCameron Randall, PhD

Clinicopathologic Expert Panel

Cameron L. Randall, PhD, is a clinical health psychologist and Acting Assistant Professor at the University of Washington School of Dentistry. His NIH-funded research focuses on pain, dental care-related fear, health behavior, and providers' implementation of evidence-based practice. This work has been recognized with awards from the NIH and the International Association for Dental Research. He co-organized the international Behavioral and Social Oral Health Sciences Summit and is a contributor for the forthcoming Surgeon General’s Report on Oral Health. As part of an interdisciplinary team, he treats patients at the University of Washington's Oral Medicine Clinic. Dr. Randall completed his graduate work at West Virginia University and his clinical psychology internship training at the University of Washington, where he was a resident in behavioral medicine and neuropsychology. He has clinical experience addressing pain, health behavior, and mental health in intensive care, burns, oncology, rehabilitation medicine, family medicine, and dental settings.

Rícheal Ní RíordáinRícheal Ní Ríordáin, BDS, PhD

Plenary Session 1B | Standardization and Validation of Patient-Centered Treatment Outcomes in Oral Mucosal Lesions

World Workshop on Oral Medicine

Rícheal Ní Ríordáin is a Consultant/Senior Lecturer in Oral Medicine in Cork University Dental School and Hospital, Honorary Associate Professor of Oral Medicine in University College London Eastman Dental Institute and Health Education England’s Regional Academic and Research Advisor for London, Kent, Surrey and Sussex. She is a member of the Steering Committee of the World Workshop on Oral Medicine VIII. Rícheal has worked both in medicine and dentistry and her research interests include patient reported outcomes and educational research with an MA in Higher Education and a PhD in Oral Medicine.

Miriam Robbins, DDS, MSMiriam Robbins, DDS, MS

Oral Medicine Practice Session Lecture 3 | Oral Health and Infectious Cardiovascular Conditions: Does the Risk of Dental Therapy Outweigh the Benefit in Patients with Compromised Cardiovascular Health?

Miriam R. Robbins, DDS, MS is the Chair of the Department of Dental Medicine at NYU Langone Hospital—Long Island as well as Chair and Associate Professor in the Department of Family Dental Medicine at the NYU Long Island School of Medicine in Mineola, NY. She is also a clinical associate professor in the Department of Oral-Maxillofacial Pathology, Radiology and Medicine at NYU College of Dentistry. She is a Diplomat of the American Board of Special Care Dentistry and a Fellow of the American College of Dentists, International College of Dentists, American Academy of Oral Medicine and American Association of Hospital Dentists. She is a past president of the American Academy of Oral Medicine and the Special Care Dentistry Association. She lectures nationally and internationally as well as contributing to the dental and medical literature on the dental management of special needs and medically complex patients.

Alan Santos-SilvaAlan Santos-Silva, DDS, MSc, PhD

Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts | Brazil

Dr. Santos-Silva received his DDS at The São Paulo State University, Brazil, followed by specialty training in Oral Medicine and Oral Pathology at University of Campinas (UNICAMP, Brazil) where he also completed a MSc and a PhD program. He completed a Doctoral Externship in Oral & Maxillofacial Pathology at The University of Sheffield, UK. Dr. Santos-Silva currently holds the position of Associate Professor in the Oral Diagnosis Department at UNICAMP where he is actively involved in teaching and research with particular interest in head and neck cancer and oral toxicities from cancer treatment with 200 publications in peer reviewed journals. ORCID: 0000-0003-2040-6617. He is Council Member of the International Association of Oral Pathologists (IAOP) and the Brazilian Society of Oral Medicine and Oral Pathology.

Thomas SollecitoThomas Sollecito, DMD, FDS RCSEd

Jonathan Ship Lecture | The Impact of Head and Neck Cancer Radiotherapy on Salivary Flow and its Subsequent Recovery: Results of the OraRad Study

Dr. Sollecito is Professor and Chair of Oral Medicine at the University of Pennsylvania, School of Dental Medicine and Professor of Oral Medicine in Otolaryngology: Head and Neck Surgery, University of Pennsylvania School of Medicine. He is also an Attending in Oral Medicine at the University of Pennsylvania Health System and the Children's Hospital of Philadelphia. He is a Fellow in Hospital Dentistry and a Diplomate in Special Care Dentistry and Oral Medicine. He is a Section Editor of the Compendium Journal and served on the ADA Council of Scientific Affairs. He was Past President of the AAOM and is serving as Vice President of the ABOM. He has authored numerous papers and chapters related to various topics in Oral Medicine.

Yee-Ping Sun, MDYee-Ping Sun, MD

Oral Medicine Practice Session Lecture 2 | Oral Health and Dental Procedures Infectious Cardiovascular Conditions: The Risk of Infection from the Cardiologist's Perspective

Yee-Ping Sun, MD FACC received his AB from Harvard College and his MD from Harvard Medical School. He completed his internal medicine training at Brigham and Women's Hospital and served as a chief medical resident there before completing his cardiology training and advanced echocardiography training at Columbia University Medical Center. He is currently an Associate Physician at Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School. He is the director of the structural heart disease imaging program and also serves as an assistant program director for the medicine residency program.

David TaubenDavid Tauben, MD, FACP

Clinicopathologic Expert Panel

David Tauben, M.D., FACP is Emeritus Clinical Professor of Medicine and Anesthesia & Pain Medicine at the University of Washington, recent Chief of the UW Division of Pain Medicine, and has practiced as Primary Care physician and Pain Medicine expert for nearly 40 years. He is Director of Medical Student Education in Pain Medicine and leads UW TelePain, an innovative tele-video-conferencing program delivering pain and opioid management educational consultative support to Pacific Northwest primary care providers. He has been principal investigator for the UW’s NIH Pain Consortium Center of Excellence for Pain Education, member of the NIH National Pain Strategy task force on Pain Education, and founding member of the State of Washington Agency Medical Directors panel of clinician experts developing opioid prescription guidelines for chronic pain. He earned his BA in Philosophy at Yale University, Medical Degree at Tufts University, and completed his Residency training at the University of Washington.

Alessandro VillaAlessandro Villa, DDS, PhD, MPh

OM-COVID Session | Can Dentists Play a Role in Ending the Pandemic?

Dr. Alessandro Villa is the chief of the Sol Silverman Oral Medicine Clinic at UCSF and the Director of Oral Oncology.  Dr. Villa obtained his dental degree and PhD from Italy and his Master of Public Health from AT Still University, MO. He then completed his oral medicine residency training at Harvard University/Brigham and Women’s Hospital and a postdoctoral fellowship at the National Cancer Institute.  Dr. Villa's research interests include the pathobiology of oral complications from cancer treatment therapeutic strategies for oral leukoplakia. In addition, Dr. Villa is working to reduce the burden of HPV-associated oropharyngeal cancers. He serves on the editorial board of several oral medicine journals, including Oral Diseases.

Inger von BültzingslöwenInger von Bültzingslöwen, DDS, PhD

Plenary Session 3 | A Global Perspective of Oral Medicine: History, Current Status, and International Collaborative Efforts | Sweden

Inger von Bültzingslöwen, researcher at the Department of Oral Microbiology and Immunology, Institute of Odontology, Sahlgrenska Academy, University of Gothenburg, Sweden, former Head of regional Division of Public Dental Health. She is past President of the Swedish Association of Orofacial Medicine and former Vice President of International Society of Oral Oncology. She was instrumental in the creation and implementation of a program for specialist training in orofacial medicine in Sweden and the establishment of orofacial medicine as a recognized dental specialty in Sweden. Her research interests are within the field of oral medicine, particularly oral side effects from cancer therapies, and she is one of the initiators and principal investigators of an ongoing international research collaboration on oral side effects from hematological malignancy treatments, the Orastem study.

American Academy of Oral Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.


Attendance American Academy of Oral Medicine designates this activity for 17 continuing education credits.


American Academy of Oral Medicine designates this activity for 14 continuing education credits.